Monday - May 04, 2026

Flowave Emerges From Stealth To Build The Agentic Infrastructure Layer For Performance-Based Advertising

The company’s autonomous AI system delivers qualified consumer actions to advertisers through organic distribution at a fraction of legacy CPM costs — replacing the outdated playbook of paid media, manual optimization, and middlemen. Flowave, Inc., a Venice, CA-based performance infrastructure … Continue reading

Prepared Food Factory Cuts RMB 170,000 in Monthly Losses Through Equipment and Packaging Upgrades in High-Humidity Conditions

Automated food processing equipment for high-humidity environments High-temperature and high-humidity conditions are emerging as key factors affecting packaging stability in prepared food production. A recent factory upgrade combining equipment and packaging improvements reduced rework from 5% to 0.3% and lowered … Continue reading

ERA-co Takes Center Stage at WRLD CTY 2026 to Lead Defining Debate on the Future of Cities in the Age of Robotics

Main Stage Debate to Explore Whether Intelligent Machines Will Improve Cities — or Render Them Obsolete Singapore – ERA-co, the strategic intelligence and placemaking advisory shaping the future of global cities, will headline WRLD CTY 2026 as the festival’s featured main … Continue reading

Graves’ Ophthalmopathy Market Forecast Analysis 2034: Clinical Trial, Pipeline, FDA Approvals and companies by DelveInsight

Graves’ Ophthalmopathy Market Graves Ophthalmopathy companies Include Novartis, Harbour BioMed, Viridian Therapeutics, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Sling Therapeutics, ValenzaBio, Argenx, HanAll Biopharma, Immunovant Sciences, Novartis, Viridian Therapeutics And Many Others The Graves’ Ophthalmopathy (Thyroid Eye Disease) market was valued … Continue reading

Duchenne Muscular Dystrophy Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Vertex Pharma, Bioleaders Corp., Wave Life Sciences, REGENXBIO

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

Lewy Body Dementia Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Jazz Pharma, Allergan, Noven Pharma, Takeda Pharma, Eli Lilly, Mallinckrodt Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading